Multiple Myeloma: Choosing the best treatment regimen in patients with high-risk cytogenetics - Part 3

December 06, 2023 00:19:56
Multiple Myeloma: Choosing the best treatment regimen in patients with high-risk cytogenetics - Part 3
COR2ED - Oncology Medical Conversation
Multiple Myeloma: Choosing the best treatment regimen in patients with high-risk cytogenetics - Part 3

Dec 06 2023 | 00:19:56

/

Show Notes

In this podcast episode, myeloma experts Dr. María Victoria Mateos (Haematologist at the University Hospital Salamanca, Spain) and Dr. Alexander Lesokhin (Associate Attending on the Myeloma Service at the Memorial Sloan Kettering Cancer Center, New York, NY, USA) discuss how they choose the best treatment regimen for patients with multiple myeloma and a high-risk cytogenetic profile. 

Firstly, they discuss the treatment options available for patients with high-risk cytogenetics in the US and in Europe. However, the key question is how to decide, for each individual, which treatment option is the best one. Dr. Mateos and Dr. Lesokhin discuss the factors they consider in these decisions in their clinical practice. Although the prior treatment is the most important consideration in the relapsed setting, the type of cytogenetic abnormality also plays a role. The experts specifically discuss treatment decisions in patients with extramedullary multiple myeloma: a difficult-to-treat population.

The speakers also discuss the future of myeloma treatment. How should trial design be adapted to better meet the needs of patients with a high-risk cytogenetic profile? What will be the role of CAR-T and bispecific antibodies in this population?

The experts conclude by summarising their key take-aways from the discussion.

Other Episodes

Episode

May 07, 2024 00:27:54
Episode Cover

Interpreting real-world evidence in later-line mCRC

What are the challenges and considerations when using real-world evidence to inform your clinical practice? How can data from real-world studies be used to...

Listen

Episode

December 03, 2024 00:26:18
Episode Cover

HCC podcast series part 2: 2nd line treatment in advanced HCC and when to switch

Join the Oncology Brothers, Drs Rahul and Rohit Gosain, as they host an insightful discussion with Dr Lorenza Rimassa and Prof. Arndt Vogel. In...

Listen

Episode

December 06, 2023 00:22:24
Episode Cover

Sarcoma: Updates from CTOS 2022

In this podcast, Prof. Jonathan Trent and Prof. Robin Jones discuss what’s new in the patient management in sarcoma from CTOS 2022. The Connective...

Listen